Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free CRNX Stock Alerts $44.71 -1.13 (-2.47%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Crinetics Pharmaceuticals Short Interest DataCurrent Short Interest4,910,000 sharesPrevious Short Interest4,910,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$247.91 millionShort Interest Ratio5.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares78,860,000 sharesPercentage of Shares Shorted6.23%Today's Trading Volume486,700 sharesAverage Trading Volume811,655 sharesToday's Volume Vs. Average60% Short Selling Crinetics Pharmaceuticals ? Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRNX Short Interest Over TimeCRNX Days to Cover Over TimeCRNX Percentage of Float Shorted Over Time Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Crinetics Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49 4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82 4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68 3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81 3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93 2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94 Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92 1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48 1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19 12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58 12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46 11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79 11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88 10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29 10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11 9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74 9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49 8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32 8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72 7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00 7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37 6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02 6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77 5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83 5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33 4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54 4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93 3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06 3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19 2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64 2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97 1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61 1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04 12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30 12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24 11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87 11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24 10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46 10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66 9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64Hurry! Buy this stock before the Robinhood traders do! (Ad)Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades 9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37 8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88 8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37 7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21 7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71 6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65 6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66 5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75 5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75 4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32 4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00 3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95 3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08 2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02 2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73 1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89 1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01 12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41 12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17 11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32 11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99 10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93 10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49 9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05 9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50 8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57 8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26 7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98 7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71 6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85 6/15/20211,330,000 shares $24.25 million -8.3%4.6%7.9 $18.23 5/28/20211,450,000 shares $25.45 million -4.6%5.0%10.2 $17.55 5/14/20211,520,000 shares $24.17 million -0.7%N/A12 $15.90 4/30/20211,530,000 shares $27.17 million -0.7%N/A11.1 $17.76 4/15/20211,540,000 shares $25.29 million +2.0%N/A11.1 $16.42 3/31/20211,510,000 shares $23.31 million -2.6%N/A11 $15.44 3/15/20211,550,000 shares $26.24 million +1.3%N/A11.1 $16.93 2/26/20211,530,000 shares $23.03 million +10.9%N/A11.2 $15.05 2/12/20211,380,000 shares $23.78 million -7.4%N/A9 $17.23 1/29/20211,490,000 shares $22.22 million +2.1%N/A9.5 $14.91 1/15/20211,460,000 shares $21.58 million +1.4%N/A8.3 $14.78 12/31/20201,440,000 shares $19.71 million +9.9%N/A8.2 $13.69 12/15/20201,310,000 shares $17.99 million +0.8%N/A8.1 $13.73 11/30/20201,300,000 shares $18.67 million +3.2%N/A8.8 $14.36 11/15/20201,260,000 shares $16.23 million +7.7%N/A9.1 $12.88 10/30/20201,170,000 shares $14.60 million -14.6%N/A9.9 $12.48 10/15/20201,370,000 shares $22.15 million -3.5%N/A13.2 $16.17 9/30/20201,420,000 shares $22.25 million +2.2%N/A14.3 $15.67 9/15/20201,390,000 shares $22.27 million -3.5%N/A8.7 $16.02 8/31/20201,440,000 shares $23.08 million -0.7%N/A7.6 $16.03Hurry! Buy this stock before the Robinhood traders do! (Ad)Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades 8/14/20201,450,000 shares $22.05 million -2.7%N/A7.1 $15.21 7/31/20201,490,000 shares $20.68 million -15.8%N/A6.8 $13.88 7/15/20201,770,000 shares $26.92 million -30.3%N/A8.1 $15.21 6/30/20202,540,000 shares $45.42 million +84.1%10.6%10.4 $17.88 6/15/20201,380,000 shares $23.54 million No Change5.7%7.2 $17.06 5/29/20201,380,000 shares $22.55 million +3.0%5.8%8.7 $16.34 5/15/20201,340,000 shares $26.40 million -11.3%N/A9.8 $19.70 4/30/20201,510,000 shares $25.82 million -5.0%N/A12.6 $17.10 4/15/20201,590,000 shares $24.61 million +0.6%10.9%14.3 $15.48 3/31/20201,580,000 shares $28.01 million +2.2%11.1%21.7 $17.73 3/13/20201,545,700 shares $21.33 million -0.3%11.0%38.6 $13.80 2/28/20201,550,000 shares $20.94 million -3.7%11.1%24.3 $13.51 2/14/20201,610,000 shares $27.45 million -10.1%11.5%24.8 $17.05 1/31/20201,790,000 shares $38.99 million -2.7%12.8%27.4 $21.78 1/15/20201,840,000 shares $40.96 million No Change13.2%30.4 $22.26 12/31/20191,840,000 shares $41.53 million -9.8%13.2%32.5 $22.57 8/15/20192,019,500 shares $34.47 million -8.6%14.9%29.3 $17.07 CRNX Short Interest - Frequently Asked Questions What is Crinetics Pharmaceuticals' current short interest? Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 4,910,000 shares of CRNX short. Learn More on Crinetics Pharmaceuticals' current short interest. What is a good short interest ratio for Crinetics Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 6.0. Learn More on Crinetics Pharmaceuticals's short interest ratio. Which institutional investors are shorting Crinetics Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Crinetics Pharmaceuticals: Walleye Trading LLC, Ikarian Capital LLC, StemPoint Capital LP, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. How does Crinetics Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Crinetics Pharmaceuticals: Avadel Pharmaceuticals plc (5.91%), Bicycle Therapeutics plc (6.76%), BeiGene, Ltd. (1.75%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Sarepta Therapeutics, Inc. (6.94%), Catalent, Inc. (3.76%), Elanco Animal Health Incorporated (3.43%), Roivant Sciences Ltd. (7.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Crinetics Pharmaceuticals stock? Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading down $1.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Crinetics Pharmaceuticals? A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further. How often is Crinetics Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Avadel Pharmaceuticals Short Interest Data Bicycle Therapeutics Short Interest Data BeiGene Short Interest Data Viatris Short Interest Data United Therapeutics Short Interest Data Dr. Reddy's Laboratories Short Interest Data Sarepta Therapeutics Short Interest Data Catalent Short Interest Data Elanco Animal Health Short Interest Data Roivant Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRNX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.